Please provide your email address to receive an email when new articles are posted on . Cystoscopies for recurrent UTIs yield little clinical benefit for patients both with and without high-risk ...
—Sharon Waisbrod, MD, discusses a systematic review and meta-analysis of prospective and retrospective studies published over an 11-year period that evaluated the prevalence of cancer in patients with ...
The guidelines state that clinicians should offer blue light cystoscopy, if available, as an adjunct to traditional white light cystoscopy (WLC) to increase tumor detection and decrease recurrence.
Diagnostic and therapeutic workup of patients with hematuria: Analysis of 1048 consective patients in a German outpatient service. This is an ASCO Meeting Abstract from the 2016 Genitourinary Cancers ...
FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study. Real-world treatment and quality of ...
A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
Non-muscle-invasive bladder cancer is labor intensive and costly to manage. Owing to long-term survival rates and life-long monitoring and treatment, it is the most expensive cancer to manage in ...
This Practice Point commentary discusses the study by Denzinger et al. in which patients with high-grade T1 (HGT1) bladder cancer were treated by transurethral resection with either white-light ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results